These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

558 related items for PubMed ID: 16125538

  • 21. Role of the hepatic sympathetic nerves in the regulation of net hepatic glucose uptake and the mediation of the portal glucose signal.
    Dicostanzo CA, Dardevet DP, Neal DW, Lautz M, Allen E, Snead W, Cherrington AD.
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E9-E16. PubMed ID: 16105863
    [Abstract] [Full Text] [Related]

  • 22. Evidence for direct action of alloxan to induce insulin resistance at the cellular level.
    Ader M, Richey JM, Bergman RN.
    Diabetologia; 1998 Nov; 41(11):1327-36. PubMed ID: 9833941
    [Abstract] [Full Text] [Related]

  • 23. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
    Kotronen A, Juurinen L, Tiikkainen M, Vehkavaara S, Yki-Järvinen H.
    Gastroenterology; 2008 Jul; 135(1):122-30. PubMed ID: 18474251
    [Abstract] [Full Text] [Related]

  • 24. The effect of pioglitazone on the liver: role of adiponectin.
    Gastaldelli A, Miyazaki Y, Mahankali A, Berria R, Pettiti M, Buzzigoli E, Ferrannini E, DeFronzo RA.
    Diabetes Care; 2006 Oct; 29(10):2275-81. PubMed ID: 17003306
    [Abstract] [Full Text] [Related]

  • 25. Berberine improves free-fatty-acid-induced insulin resistance in L6 myotubes through inhibiting peroxisome proliferator-activated receptor gamma and fatty acid transferase expressions.
    Chen Y, Li Y, Wang Y, Wen Y, Sun C.
    Metabolism; 2009 Dec; 58(12):1694-702. PubMed ID: 19767038
    [Abstract] [Full Text] [Related]

  • 26. Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats.
    Minoura H, Takeshita S, Kimura C, Hirosumi J, Takakura S, Kawamura I, Seki J, Manda T, Mutoh S.
    Diabetes Obes Metab; 2007 May; 9(3):369-78. PubMed ID: 17391165
    [Abstract] [Full Text] [Related]

  • 27. Pharmacological characteristics of a novel nonthiazolidinedione insulin sensitizer, FK614.
    Minoura H, Takeshita S, Ita M, Hirosumi J, Mabuchi M, Kawamura I, Nakajima S, Nakayama O, Kayakiri H, Oku T, Ohkubo-Suzuki A, Fukagawa M, Kojo H, Hanioka K, Yamasaki N, Imoto T, Kobayashi Y, Mutoh S.
    Eur J Pharmacol; 2004 Jun 28; 494(2-3):273-81. PubMed ID: 15212984
    [Abstract] [Full Text] [Related]

  • 28. Effects of pioglitazone on hepatic and peripheral insulin resistance in Wistar fatty rats.
    Sugiyama Y, Shimura Y, Ikeda H.
    Arzneimittelforschung; 1990 Apr 28; 40(4):436-40. PubMed ID: 2192715
    [Abstract] [Full Text] [Related]

  • 29. Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites.
    Lam TK, van de Werve G, Giacca A.
    Am J Physiol Endocrinol Metab; 2003 Feb 28; 284(2):E281-90. PubMed ID: 12531742
    [Abstract] [Full Text] [Related]

  • 30. Increased responses of glucagon and glucose production to hypoglycemia with intraperitoneal versus subcutaneous insulin treatment.
    Wan CK, Giacca A, Matsuhisa M, El-Bahrani B, Lam L, Rodgers C, Shi ZQ.
    Metabolism; 2000 Aug 28; 49(8):984-9. PubMed ID: 10954014
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Determinants of glucose turnover in the pathophysiology of diabetes: an in vivo analysis in diabetic dogs.
    Fisher SJ, Lekas MC, McCall RH, Shi ZQ, Giacca A, Vranic M.
    Diabetes Metab; 1996 Apr 28; 22(2):111-21. PubMed ID: 8792091
    [Abstract] [Full Text] [Related]

  • 33. Effects of the nitric oxide donor SIN-1 on net hepatic glucose uptake in the conscious dog.
    An Z, DiCostanzo CA, Moore MC, Edgerton DS, Dardevet DP, Neal DW, Cherrington AD.
    Am J Physiol Endocrinol Metab; 2008 Feb 28; 294(2):E300-6. PubMed ID: 18029444
    [Abstract] [Full Text] [Related]

  • 34. Effect of intraportal glucagon-like peptide-1 on glucose metabolism in conscious dogs.
    Nishizawa M, Moore MC, Shiota M, Gustavson SM, Snead WL, Neal DW, Cherrington AD.
    Am J Physiol Endocrinol Metab; 2003 May 28; 284(5):E1027-36. PubMed ID: 12569088
    [Abstract] [Full Text] [Related]

  • 35. Hyperglycemia prevents the suppressive effect of hyperinsulinemia on plasma adiponectin levels in healthy humans.
    Blümer RM, van der Crabben SN, Stegenga ME, Tanck MW, Ackermans MT, Endert E, van der Poll T, Sauerwein HP.
    Am J Physiol Endocrinol Metab; 2008 Sep 28; 295(3):E613-7. PubMed ID: 18577692
    [Abstract] [Full Text] [Related]

  • 36. Effect of GCP-02, a PPARalpha/gamma dual activator, on glucose and lipid metabolism in insulin-resistant mice.
    Wang ZJ, Liu Q, Li PP, Zou CH, Shen ZF.
    Eur J Pharmacol; 2008 Feb 02; 580(1-2):277-83. PubMed ID: 18048028
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effects of colostrum feeding and glucocorticoid administration on insulin-dependent glucose metabolism in neonatal calves.
    Scheuer BH, Zbinden Y, Schneiter P, Tappy L, Blum JW, Hammon HM.
    Domest Anim Endocrinol; 2006 Oct 02; 31(3):227-45. PubMed ID: 16360295
    [Abstract] [Full Text] [Related]

  • 40. 10-day hyperlipidemic clamp in cats: effects on insulin sensitivity, inflammation, and glucose metabolism-related genes.
    Zini E, Osto M, Konrad D, Franchini M, Sieber-Ruckstuhl NS, Kaufmann K, Guscetti F, Ackermann M, Lutz TA, Reusch CE.
    Horm Metab Res; 2010 May 02; 42(5):340-7. PubMed ID: 20162504
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.